The aims of the study were to review the rapidly emerging COVID-19 literature to determine 1) the relationship between obstructive sleep apnoea (OSA) and adverse COVID-19 outcomes and, 2) potential causal mechanisms 3) what effect COVID-19 has had on OSA diagnosis and 4) what effect COVID-19 has had on treatment and management of OSA during this period. PubMed was systematically searched up to 020620. Studies were included if they had examined the relationship between COVID-19 and OSA. Studies were included that were in English and had the full text available. The findings from this study suggest that many of the risk factors and co-morbidities associated for OSA which include obesity, hypertension and diabetes mellitus are associated with poor COVID-19 outcomes. There are plausible mechanisms by which OSA may independently increase one's risk of morbidity and mortality associated with COVID-19 and data from the newly published CORONADO study suggests that OSA treated patients may be at increased risk of death from COVID-19. It is clear that the pandemic has had a major effect on the treatment management and diagnosis of OSA and moving forward it may be necessary to explore new diagnosis and treatment pathways for these individuals.

该研究的目的是回顾迅速出现的 COVID-19 文献，以确定 1) 阻塞性睡眠呼吸暂停 (OSA) 与 COVID-19 不良结果之间的关系，以及 2) 潜在的因果机制 3) COVID-19 产生了什么影响对 OSA 诊断的影响以及 4）在此期间 COVID-19 对 OSA 的治疗和管理有何影响。PubMed 被系统地搜索到 020620。如果研究检查了 COVID-19 和 OSA 之间的关系，则将其包括在内。纳入的研究是英文的，并提供全文。这项研究的结果表明，与 OSA 相关的许多危险因素和合并症，包括肥胖、高血压和糖尿病，都与 COVID-19 的不良结果有关。OSA 可以通过合理的机制独立增加一个' 与 COVID-19 相关的发病率和死亡率风险以及来自新发表的 CORONADO 研究的数据表明，接受 OSA 治疗的患者死于 COVID-19 的风险可能增加。很明显，大流行对 OSA 的治疗管理和诊断产生了重大影响，向前推进可能有必要为这些人探索新的诊断和治疗途径。